Tohmé, R., Izadmehr, S., Gandhe, S., Tabaro, G., Vallabhaneni, S., Thomas, A., . . . Narla, G. (2019). Direct activation of PP2A for the treatment of tyrosine kinase inhibitor–resistant lung adenocarcinoma. JCI Insight.
Chicago Stili AlıntıTohmé, Rita, et al. "Direct Activation of PP2A for the Treatment of Tyrosine Kinase Inhibitor–resistant Lung Adenocarcinoma." JCI Insight 2019.
MLA AlıntıTohmé, Rita, et al. "Direct Activation of PP2A for the Treatment of Tyrosine Kinase Inhibitor–resistant Lung Adenocarcinoma." JCI Insight 2019.
Uyarı: Bu alıntı herzaman %100 doğru olmayabilir..